An $80 (USD) nonrefundable submission fee will be charged per abstract submitted. Payment is due at the time of submission. Credit cards are the only accepted form of payment. Checks, wire transfers, and purchase orders will not be accepted. Please note: The abstract submission fee does not...
An $80 (USD) nonrefundable submission fee will be charged per abstract submitted. Payment is due at the time of submission. Credit cards are the only accepted form of payment. Checks, wire transfers, and purchase orders will not be accepted. Please note: The abstract submission fee does not...
A novel artificial intelligence (AI)-based model could accurately classify sarcomas among pediatric patients using digital pathology images alone, according to new findings presented by Thiesen et al at the 2025 American Association for Cancer Research (AACR) Annual Meeting (Abstract 2423/8)... Survi...
Abstract Number: 461Poster Session: Poster Session C: Renal Cell Cancer; Penile, Testicular and Urethral CancersPoster Board: D29Date and Time: Saturday, February 15, 2025, 7:10-8:10 AM PT and 11:30 AM-12:45 PM PTLocation: Level 1, West Hall...
Submission Fee:A $60 (USD) nonrefundable submission fee will be charged per abstract submitted. Payment is due at the time of submission. ASGO GI 2025 注册费: 线下:In-Person Registration Fees *Special Rate Categories (Additional information required to verify nonmember attendee eligibility for thes...
Abstract 5080: Axitinib plus pembrolizumab in patients with advanced renal cell carcinoma: Long-term efficacy and safety from a phase Ib study. Michael B. Atkins, Igor Puzanov, Elizabeth R. Plimack et al. Results:At data cut-off date (July 3, 2019), median OS was not reached; 38 (73....
Submission Fee:A $60 (USD) nonrefundable submission fee will be charged per abstract submitted. Payment is due at the time of submission. ASGO GU 2024 注册费: 线下:In-Person Registration Fees *Special Rate Categories (Additional information required to verify attendee eligibility for these nonmembe...
Abstract The HER2 gene is amplified and overex- pressed in about 15%–20% of breast can- cers. For every newly diagnosed breast can- cer HER2 testing is a standard routine proce- dure. This article focuses on a number of is- sues raised in the context of current HER2 testing in ...
Abstract 美国临床肿瘤学会(ASCO)指南提供了每项建议的全面文献审查和分析,并遵循ASCO指南方法手册中概述的指南制定流程。ASCO指南遵循ASCO临床实践指南利益冲突政策。 ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guidelin...
Date and Time: 06/05/2022, 8:00 AM - 11:00 AM Presentation Time/Duration: 9:12 AM - 9:24 AM Abstract Title: Phase I open-label single arm study of GPRC5D CAR T-cells (OriCAR-017) in patients with relapse...